Clinical Trial Update: Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating gemcitabine in patients with metastatic cancer of unknown primary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Carcinoma of Unknown Primary, Pain | Phase 2 | Status: COMPLETED